93 related articles for article (PubMed ID: 15314639)
1. Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia.
Gandour-Edwards R; Mack PC; Devere-White RW; Gumerlock PH
Prostate Cancer Prostatic Dis; 2004; 7(4):321-6. PubMed ID: 15314639
[TBL] [Abstract][Full Text] [Related]
2. Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation.
Cardillo M; Berchem G; Tarkington MA; Krajewski S; Krajewski M; Reed JC; Tehan T; Ortega L; Lage J; Gelmann EP
J Urol; 1997 Jul; 158(1):212-6. PubMed ID: 9186362
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.
Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G
Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
Wang W; Bergh A; Damber JE
Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of PCNA and p27 in benign prostate hypertrophy and prostate carcinoma].
Lai JS; Xia Q; Zhang XB; Zhao GP; Xu SL; Zheng DS
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):476-8. PubMed ID: 15555337
[TBL] [Abstract][Full Text] [Related]
6. Reverse transcriptase-PCR analysis of apoptosis-regulating gene expression in human benign prostatic hyperplasia.
Angelucci C; Iacopino F; Lama G; Zelano G; Gianesini G; Sica G; Bono AV
Anticancer Res; 2005; 25(6B):3937-41. PubMed ID: 16309180
[TBL] [Abstract][Full Text] [Related]
7. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis profiles in benign prostatic hyperplasia: close associations of cell kinetics with percent area density of histologic composition.
Zhang X; Zhang Q; Zhang Z; Na Y; Guo Y
Urology; 2006 Oct; 68(4):905-10. PubMed ID: 17070390
[TBL] [Abstract][Full Text] [Related]
9. [Expression of Ki-67, Bcl-2,Bax and caspase-3 in benign prostatic hyperplasia combined with prostatitis and their significances].
Wang L; Yang JR; Yang LY; Liu ZT; Rao JM; Liu LF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):222-6. PubMed ID: 18382056
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
Vereide AB; Kaino T; Sager G; Ørbo A;
Gynecol Oncol; 2005 Jun; 97(3):740-50. PubMed ID: 15885761
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of p27(Kip 1) cyclin-dependent kinase inhibitor in prostate cancer: distinct expression in various prostate cells associating with tumor stage and grades.
Nikoleishvili D; Pertia A; Tsintsadze O; Gogokhia N; Chkhotua A
Georgian Med News; 2007 Feb; (143):34-8. PubMed ID: 17404436
[TBL] [Abstract][Full Text] [Related]
12. Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21.
Shen ZN; Nishida K; Doi H; Oohashi T; Hirohata S; Ozaki T; Yoshida A; Ninomiya Y; Inoue H
Biochem Biophys Res Commun; 2005 Mar; 328(2):375-82. PubMed ID: 15694358
[TBL] [Abstract][Full Text] [Related]
13. P21 and Bax expression in cutaneous malignant melanomas: correlation with histologic prognostic parameters.
Poyraz A; Akyürek N; Gönül II; Erdem O
J Exp Clin Cancer Res; 2004 Dec; 23(4):625-31. PubMed ID: 15743033
[TBL] [Abstract][Full Text] [Related]
14. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
[TBL] [Abstract][Full Text] [Related]
15. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
16. Identification of genes associated with stromal hyperplasia and glandular atrophy of the prostate by mRNA differential display.
Walden PD; Lefkowitz GK; Ficazzola M; Gitlin J; Lepor H
Exp Cell Res; 1998 Nov; 245(1):19-26. PubMed ID: 9828097
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
Venkataraman G; Maududi T; Ozpuyan F; Bahar HI; Izban KF; Qin JZ; Alkan S
Leuk Res; 2006 Nov; 30(11):1377-84. PubMed ID: 16624404
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
Sabah M; Cummins R; Leader M; Kay E
Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
[TBL] [Abstract][Full Text] [Related]
19. [Cell apoptosis and proliferation in the transition and peripheral zones in human prostate].
Sun HB; Xia SJ
Zhonghua Nan Ke Xue; 2007 Feb; 13(2):110-3. PubMed ID: 17345763
[TBL] [Abstract][Full Text] [Related]
20. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
Wang W; Zhang X; Mize GJ; Takayama TK
Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
